INTRODUCTION

Origin country: Romania

Target market: USA
Name of the product: AccuMemories (accurate memories)
Legal form: LLC SRL (Societate cu rspundere limitat) in Romania
Headquarters/Laboratories location: Str. Logoft Tutu nr. 99
Phone number: +40724639799
Email: info@accumemories.com
Management Directory
1. Cristian Radu, Chief Researcher and Chief Executive Officer
2. Claudia Nedeianu, Operations Manager
3. Th Phm, Sales Manager
4. Tatyana Vorobel, Logistics&Distribution Executive
5. Max Ivanitzki, Marketing Manager

Company Overview

AccuMemories emerged when the trials on rats started, thus supporting the Romanian
research team. We were very sure that this was going to be something extraordinary for
medicine and neuroscience, so we opened right away our headquarters.
AccuMemories is now considered to be a leading supplier of memory chips in clinics around
the world, but also cooperating with top institutes of neurosciences that are interested to buy
our product patent for future development or use. We are very happy that we chose Romania,
which turned out to be an oasis for our business thanks to the talented researchers working
there.

Around the world, more than 44 million people suffer from Alzheimer's disease or conditions
related to dementia. Researchers at the Polytechnic University of Bucharest and the National
Institute of Biochemistry in Romania have developed a brain chip designed to help
individuals suffering from memory loss associated with Alzheimer's Disease, even if the
memory center of the brain, called hippocampus, is damaged. It has also been proved to work
in severe cases of epilepsy, when patients have no luck with classical treatment.
The research started in 2004 and last year we finished our last clinical trial, which performed
well on human patients as well as the tests completed on rats (laboratory testing on rats was
done in conjunction with the testing on humans, because the studies showed similar pattern of
electronic impulses for the memory center on both of them). It has been approved by the FDA
and it has achieved support from the National Medical Congress of Romania in 2016, as an
alternative treatment.
Thus, this memory chip would come in handy as a treatment for Alzheimer's disease, saving
millions of people from dying every year due to the neurological damage. For more than
three decades, our team in Romania have been researching for this silicone chip that can
adapt to the brain tissue and might be used someday to repaired damaged or diseased brain
tissue.

Description

This silicon-based chip (5mm size) acts as a brain tissue, activated through a device after it
has been implanted in the brain (the surgery is laparoscopic, non-invasive, and lasts around
2h) and after the post-operation period passed (healing time is around 2 weeks to 1 month).
Because it uses electronic impulses, each patient gets specific and suited treatment for their
Alzheimer's, epilepsy or dementia diagnosis every 12h or 6h stimulation for regenerating
brain tissue, depending on age, severity of disease, risks (criteria assessed by their
neurosurgeon).
As a complementary treatment, painkillers and anticoagulant medication is used in the first
stages of chip activation (after 3 months and complete healing, anticoagulant treatment stops
and tests are being done every month in order too see improvement in memory and brain
condition).

How does it work?

When the brain receives the electronic input, it creates a space for the memory to form in the
multiple regions of the hippocampus. At each region, the signal is re-encoded until it reaches
the final region as a wholly different signal that is sent off for long-term storage. Therefore,
the signal is translated into an action of the brain to form new memories. However, there is a
possibility that severe damage would not allow long-term memories to be formed, thus
people won't be able to remember events from long-time ago.
The main role of this microchip is curing Alzheimer's disease, but it can also have beneficial
effects on people suffering from epilepsy. Our team in Romania has designed this chip to
bypass a damaged hippocampal section and provide the next region with the correctly
translated memory, despite the fact that there is currently no way of reading a memory just by
looking at its electrical signal. Its like being able to translate from Spanish to French without
being able to understand either language.
Target group: patients with memory loss problem (for example Alzheimer), only as an
extension of the treatment (it is not recommended as a general treatment for Alzheimer, but
rather as a solution for people that are able to go under surgery for this), people with
dementia, people that do not respond to epilepsy treatment.